{
    "2019-10-10": [
        [
            {
                "time": "2019-10-10",
                "original_text": "数据复盘｜15亿主力资金流入创业板个股，逾6亿机构资金卖出这些股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "创业板",
                        "机构资金"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-10",
                "original_text": "医药大礼包来了：多股涨停，“一哥”创历史收盘新高",
                "features": {
                    "keywords": [
                        "医药",
                        "涨停",
                        "一哥"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-10",
                "original_text": "《第一批鼓励仿制药品目录》：强化药品供应保障，鼓励仿制药品目录发布进入常态化",
                "features": {
                    "keywords": [
                        "仿制药品",
                        "目录",
                        "常态化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-10",
                "original_text": "恒瑞董事长：已暂停部分仿制药项目，药品集中采购无可非议 项目问题",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "仿制药",
                        "暂停",
                        "集中采购"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09",
                "original_text": "2019年9月外资持仓变动跟踪：北上资金强势流入，持仓集中度下降",
                "features": {
                    "keywords": [
                        "外资",
                        "北上资金",
                        "持仓集中度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-10",
                "original_text": "方正证券：四类核心资产或将持续成为医药行业最佳投资方向",
                "features": {
                    "keywords": [
                        "方正证券",
                        "核心资产",
                        "医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-10",
                "original_text": "卫健委发布癌症防治方案，新药发展再次迎来推力",
                "features": {
                    "keywords": [
                        "卫健委",
                        "癌症防治",
                        "新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}